GoAI
Get started
Phreesia, Inc. logo

Phreesia, Inc.

PHR

NYSEHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$12.12

+$0.12 · +1.00%

Aug 21, 4:00 PM ET

PHR company overview

Historical prices · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

62

Undervalued

Momentum

32

Weakening

Sentiment

60

Mixed

Risk resilience

36

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $12.12

52-week range

Current $12.12

Open
$11.98
Previous close
$12.00
Volume
773.83K
Market cap
749.16M USD
50-day average
$10.7464
+12.78% above average
200-day average
$12.8255
-5.50% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
830.9M USD
P/E (TTM)
79.63×
P/B (TTM)
2.06×
P/S (TTM)
1.51×
EV / EBITDA
28.2×
Earnings yield
0.29%
Free cash flow yield
8.44%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
65.81%
Operating margin
0.73%
Net margin
1.85%
Return on equity
0.68%
Return on assets
0.35%
Return on invested capital
0.35%

Financial health

Debt / equity
0.26×
Current ratio
1.53×
Altman Z-score
0.78
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends81%29%-24%-76%Gross margin, FY2022: 61.83%Gross margin, FY2023: 61.10%Gross margin, FY2024: 65.19%Gross margin, FY2025: 67.86%Gross margin, FY2026: 67.93%Operating margin, FY2022: -54.78%Operating margin, FY2023: -62.85%Operating margin, FY2024: -38.30%Operating margin, FY2025: -13.84%Operating margin, FY2026: -1.38%Net margin, FY2022: -55.41%Net margin, FY2023: -62.71%Net margin, FY2024: -38.42%Net margin, FY2025: -13.94%Net margin, FY2026: 0.48%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 61.83%. Gross margin FY2023 61.10%. Gross margin FY2024 65.19%. Gross margin FY2025 67.86%. Gross margin FY2026 67.93%. Operating margin FY2022 -54.78%. Operating margin FY2023 -62.85%. Operating margin FY2024 -38.30%. Operating margin FY2025 -13.84%. Operating margin FY2026 -1.38%. Net margin FY2022 -55.41%. Net margin FY2023 -62.71%. Net margin FY2024 -38.42%. Net margin FY2025 -13.94%. Net margin FY2026 0.48%.

Income trends

Revenue

480.59M USD+14.48%

Operating income

−6.61M USD+88.62%

Net income

2.31M USD+60.83M USD
Income trends across reported periods546.31M USD283.45M USD20.59M USD−242.27M USDRevenue, FY2022: 213.23M USDRevenue, FY2023: 280.91M USDRevenue, FY2024: 356.3M USDRevenue, FY2025: 419.81M USDRevenue, FY2026: 480.59M USDOperating income, FY2022: −116.82M USDOperating income, FY2023: −176.55M USDOperating income, FY2024: −136.48M USDOperating income, FY2025: −58.1M USDOperating income, FY2026: −6.61M USDNet income, FY2022: −118.16M USDNet income, FY2023: −176.15M USDNet income, FY2024: −136.89M USDNet income, FY2025: −58.53M USDNet income, FY2026: 2.31M USDFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 213.23M USD. Revenue FY2023 280.91M USD. Revenue FY2024 356.3M USD. Revenue FY2025 419.81M USD. Revenue FY2026 480.59M USD. Operating income FY2022 −116.82M USD. Operating income FY2023 −176.55M USD. Operating income FY2024 −136.48M USD. Operating income FY2025 −58.1M USD. Operating income FY2026 −6.61M USD. Net income FY2022 −118.16M USD. Net income FY2023 −176.15M USD. Net income FY2024 −136.89M USD. Net income FY2025 −58.53M USD. Net income FY2026 2.31M USD.
Metric (USD)FY2026FY2025FY2024FY2023FY2022
Revenue480.59M USD419.81M USD356.3M USD280.91M USD213.23M USD
Cost of goods sold154.12M USD134.93M USD124.01M USD109.27M USD81.39M USD
Gross profit326.47M USD284.88M USD232.29M USD171.64M USD131.85M USD
Research and development121.48M USD117.36M USD112.35M USD91.24M USD52.27M USD
Selling, general, and administrative180.15M USD197.73M USD226.93M USD231.65M USD175.1M USD
Operating expenses333.08M USD342.98M USD368.77M USD348.2M USD248.66M USD
Interest income2.17M USD2.68M USD4.07M USD2.48M USD79K USD
Interest expense6.95M USD2.35M USD1.85M USD1.41M USD1.16M USD
Depreciation and amortization31.45M USD27.89M USD30.54M USD28.77M USD24.52M USD
Operating income−6.61M USD−58.1M USD−136.48M USD−176.55M USD−116.82M USD
Net income2.31M USD−58.53M USD−136.89M USD−176.15M USD−118.16M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Recent analyst actions

12 institutions
CitizensdowngradeMarket OutperformMarket Perform

PHR peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding PHR

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
19.71M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
15.62M
Weight
0.02%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
7.23M
Weight
0.01%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Fidelity Enhanced Small Cap ETF logoFidelity Enhanced Small Cap ETFFESM
Market value
5.82M
Weight
0.09%
AUM
6.03B USD
Expense ratio
0.28%
Price / 1D
$47.94+0.80%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
4.62M
Weight
0.03%
AUM
15.16B USD
Expense ratio
0.24%
Price / 1D
$387.37+1.24%
VictoryShares Small Cap Free Cash Flow ETF logoVictoryShares Small Cap Free Cash Flow ETFSFLO
Market value
3.64M
Weight
0.46%
AUM
778.53M USD
Expense ratio
0.56%
Price / 1D
$39.77+0.63%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
3.34M
Weight
0.01%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
2.97M
Weight
0.02%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%

Continue in GoAI

Research PHR

research.disclaimer